Design, synthesis and evaluation of peroxisome proliferator-activated receptor α/γ dual agonists for the treatment of type 2 diabetes

被引：0
作者：
Das, Saibal Kumar [1 ]
Abbineni, Chandrasekhar [1 ]
Rao, Krovvidi Venkata Lakshmi Narasimha [1 ]
Iqbal, Javed [1 ]
Babu, Ravi Krishna [1 ]
Chakrabarti, Ranjan [1 ]
机构：
[1] Dr Reddys Labs Ltd, Metab Disorders Grp, Discovery Res, Hyderabad 500049, Andhra Pradesh, India
来源：
LETTERS IN DRUG DESIGN & DISCOVERY | 2007年 / 4卷 / 01期
关键词：
PPAR; diabetes; synthesis; ethyl 3-(4-aminophenyl)-2-ethoxypropionate; dyslipidemia and plasma glucose;
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The design, synthesis and evaluation of several dual PPAR alpha/gamma agonists with three different heterocycles, viz. pyrazolo[4,3-d]pyrimidin-7-one, quinazolin-4-one and benzo[e][1,3]oxazine-4-one for the treatment of type 2 diabetes and associated dyslipidemia are described. Among them, compound 5cb was found to possess a potent dual PPAR alpha/gamma agonist property. It significantly reversed diabetic hyperglycemia while improving overall lipid homeostasis in preclinical animal models.
引用
收藏
页码：27 / 32
页数：6
相关论文
共 50 条
  • [11] From Dual Peroxisome Proliferator Activated Receptor Agonists to Selective Peroxisome Proliferator Activated Receptor Modulators
    Dagdelen, Selcuk
    RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY, 2008, 2 (01) : 24 - 28
  • [12] Design, synthesis, and evaluation of a novel series of α-substituted phenylpropanoic acid derivatives as human peroxisome proliferator-activated receptor (PPAR) α/δ dual agonists for the treatment of metabolic syndrome
    Kasuga, Jun-ichi
    Yamasaki, Daisuke
    Araya, Yoko
    Nakagawa, Aya
    Makishima, Makoto
    Doi, Takefumi
    Hashimoto, Yuichi
    Miyachi, Hiroyuki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (24) : 8405 - 8414
  • [13] Dual peroxisome proliferator-activated receptor α/δ agonists: Hope for the treatment of alcohol-associated liver disease?
    Zhang, Xin-Yang
    Chen, Qin-Jun-Jie
    Zhu, Feng
    Li, Min
    Shang, Dan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (37) : 4163 - 4167
  • [14] Synthesis and Structure-Activity Relationships of 2-Aminoacetamide Derivatives as Peroxisome Proliferator-Activated Receptor α/γ Dual Agonists
    Shibata, Yoshihiro
    Kagechika, Katsuji
    Ota, Masahiro
    Yamaguchi, Mitsuhiro
    Setoguchi, Masaki
    Kubo, Hideo
    Chiba, Kiyoshi
    Takano, Hiromichi
    Akiyama, Chiyuki
    Ono, Mayumi
    Nishi, Mina
    Usui, Hiroyuki
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2015, 63 (08) : 591 - 602
  • [15] Recent Updates on Peroxisome Proliferator-Activated Receptor Agonists for the Treatment of Metabolic Syndrome
    Grewal, Ajmer S.
    Beniwal, Meenu
    Pandita, Deepti
    Sekhon, Bhupinder S.
    Lather, Viney
    MEDICINAL CHEMISTRY, 2016, 12 (01) : 3 - 21
  • [16] Design, synthesis, and biological evaluation of a series of alkoxy-3-indolylacetic acids as peroxisome proliferator-activated receptor γ/δ agonists
    Gim, Hyo Jin
    Li, Hua
    Jeong, Ji Hye
    Lee, Su Jeong
    Sung, Mi-Kyung
    Song, Mi-Young
    Park, Byung-Hyun
    Oh, Soo Jin
    Ryu, Jae-Ha
    Jeon, Raok
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (13) : 3322 - 3336
  • [17] Design, Synthesis, and Structure-Activity Relationships of Bavachinin Analogues as Peroxisome Proliferator-Activated Receptor Agonists
    Du, Guoxin
    Zhao, Yuanyuan
    Feng, Li
    Yang, Zhuo
    Shi, Jiye
    Huang, Cheng
    Li, Bo
    Guo, Fujiang
    Zhu, Weiliang
    Li, Yiming
    CHEMMEDCHEM, 2017, 12 (02) : 183 - 193
  • [18] Genetic Variation in the Peroxisome Proliferator-Activated Receptor (PPAR) and Peroxisome Proliferator-Activated Receptor Gamma Co-activator 1 (PGC1) Gene Families and Type 2 Diabetes
    Villegas, Raquel
    Williams, Scott M.
    Gao, Yu-Tang
    Long, Jirong
    Shi, Jiajun
    Cai, Hui
    Li, Honglan
    Chen, Ching-Chu
    Tai, E. Shyong
    Hu, Frank
    Cai, Qiuyin
    Zheng, Wei
    Shu, Xiao-Ou
    ANNALS OF HUMAN GENETICS, 2014, 78 (01) : 23 - 32
  • [19] Novel peroxisome proliferator-activated receptor ligands for Type 2 diabetes and the metabolic syndrome
    Miller, AR
    Etgen, GJ
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (09) : 1489 - 1500
  • [20] Peroxisome proliferator-activated receptor (PPAR α/γ) agonists as a potential target to reduce cardiovascular risk in diabetes
    Nicholls, Stephen J.
    Uno, Kiyoko
    DIABETES & VASCULAR DISEASE RESEARCH, 2012, 9 (02) : 89 - 94
12345